Differentiation of classes of neurosedatives using rats with septal lesions.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D001522:Behavior, Animal / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000502:physiology*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D006613:Higher Nervous Activity / Q000187:drug effects*; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D008620:Meprobamate / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D013223:Statistics as Topic; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology
D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D002707:Chlordiazepoxide; D008620:Meprobamate; D000654:Amobarbital; D010424:Pentobarbital; D002746:Chlorpromazine; D010634:Phenobarbital